Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections
Lee, J-Jung.; Song, H-Chun.; Chung, I-Joo.; Bom, H-Seung.; Cho, D.; Kim, H-Joon.
Haematologica 89(5): 632-633
2004
ISSN/ISBN: 0390-6078 PMID: 15136239 Document Number: 575302
We investigated the efficacy of transfusing granulocytes into 32 patients with severe neutropenia-related infections and the factors that predict response to this therapy. Our findings suggest that granulocyte transfusion therapy is useful for treating neutropenic patients with fungal infections and that 99mTc-HMPAO-granulocyte scintigraphy can be used to predict response to granulocyte transfusion therapy.
Document emailed within 1 workday
Related Documents
Vivancos Pujol, M.P.; Alemany, A.; Clavo, M.; Rubio Baget, A.; Sans Botargues, R.; Ferran, C. 1979: Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient Sangre 24(5b): 896-903Garavelli, P.L. 1992: Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report Haematologica 77(3): 293-294
Hung, M.J.; Wang, C.H.; Cherng, W.J. 2002: Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia International Journal of Clinical Practice 56(1): 70-71
Fassas, A.; Papageorgiou, T.; Kontodimou, A.; Proya, E.; Hadjikyrkou, M.; Anagnostopoulos, A. 1989: Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia Journal of ChemoTherapy 1(4 Suppl): 1295-1297
Korsak, J. 2008: Clinical application of granulocyte concentrates in neutropenia caused by immunosupressive treatment Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 346-350
Schroten, H.; Roesler, J.; Breidenbach, T.; Wendel, U.; Elsner, J.; Schweitzer, S.; Zeidler, C.; Burdach, S.; Lohmann-Matthes, M.L.; Wahn, V. 1991: Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib Journal of Pediatrics 119(5): 748-754
Parco, S.; Bruno, G.; Durighello, M.; Giorgini, R.; Pikiz, L.; Andolina, M. 1998: Granulocyte transfusion in leukopenic children by simplified leukapheresis of related donors International Journal of Artificial Organs 21(1): 63-64
Bláha, M.; Jebavý, L.; Vanásek, J.; Maisnar, V.; Malý, J.; Pecka, M.; Siroký, O. 1987: Granulocyte transfusion therapy Vnitrni Lekarstvi 33(10): 883-888
Uchida, T.; Kariyone, S. 1973: Intravascular granulocyte kinetics and spleen size in patients with neutropenia and chronic splenomegaly Journal of Laboratory and Clinical Medicine 82(1): 9-19
Weston, B.; Todd, R.F.; Axtell, R.; Balazovich, K.; Stewart, J.; Locey, B.J.; Mayo-Bond, L.; Loos, P.; Hutchinson, R.; Boxer, L.A. 1991: Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor Journal of Laboratory and Clinical Medicine 117(4): 282-290
Durand-Gasselin, B.; Lortholary, O.; Tod, M.; Guillevin, L.; Casassus, P. 1997: Efficacy of teicoplanin in Staphylococcus aureus catheter-related tricuspid endocarditis during severe neutropenia Annales de Medecine Interne 148(7): 502-503
Beguin, Y. 2002: Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients Haematologica 87(11): 1209-1221
Ohnoshi, T.; Ueoka, H.; Kodani, T.; Kamei, H.; Kimura, I. 1990: Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 2): 911-918
Kitamura, K.; Miyagawa, K.; Urabe, A.; Sato, H.; Obayashi, Y.; Aoki, I.; Takaku, F.; Togawa, A.; Shindou, E.; Wakabayashi, Y.; Ohshima, T.; Horikoshi, A.; Nomura, T.; Ohki, I.; Suzuki, K.; Kamakura, M.; Oguchi, A.; Toyama, K.; Yaguchi, M.; Aoki, N.; Kato, A.; Mizoguchi, H.; Masuda, M.; Irie, S.; Fujioka, S. 1996: Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders Japanese Journal of Antibiotics 49(12): 1062-1072
Hanada, N.; Tanaka, S.; Takahata, T.; Sato, A. 2014: Use of granulocyte-colony stimulating factor(G-CSF)in patients with cancer at high risk of febrile neutropenia on the basis of high age and complications, recommendations for patients receiving radiotherapy, and adverse events because of G-CSF Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(6): 702-706
Shi, Y.-k.; He, X.-h.; Yang, S.; Wang, H.-q.; Jiang, Z.-f.; Zhu, Y.-z.; Ke, X.-y.; Zhang, Y.; Liu, Y.-p.; Zhang, W.-j.; Wang, Z.; Shi, Q.-z.; Xie, X.-d.; Zhang, H.-l.; Wang, J.-j.; Luo, D.-y.; Zheng, Q.-s.; Sun, R.-y. 2006: Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase Ii clinical study Zhonghua Yi Xue Za Zhi 86(48): 3414-3419
Kamanabroo, D.; Jansen, M.; Gröbe, H.; Büchner, T. 1978: Granulocyte transfusion for the treatment of septic conditions in neutropenic patients Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 937-939
Payne, P.D.; Henry, B.; Smith, E.A.; Baddour, L.M. 1994: Lack of quinolone efficacy in two oncology patients with catheter-related infections caused by coagulase-negative staphylococci Journal of the Tennessee Medical Association 87(7): 285-287
Hazra, S.C.; Chatterjee, S.; Das Gupta, S.; Chaudhuri, U.; Jana, C.K.; Neogi, D.K. 2002: Changing scenario of transfusion-related viral infections Journal of the Association of Physicians of India 50: 879-881
Iakovlev, V.P.; Krutikov, M.G.; Blatun, L.A.; Izotova, G.N.; Grishina, I.A. 2000: Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections Antibiotiki i Khimioterapiia 45(12): 37-40